PA
KRP icon

PharVision Advisers’s Kimbell Royalty Partners KRP Stock Holding History

PharVision Advisers’s Portfolio KRP Stock Details KRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,913
Closed -$180K – 731
2025
Q2 		$180K Buy
+12,913
New +$169K 0.26% 215

Other funds holding KRP

EECFV
EnCap Energy Capital Fund VIII Houston, Texas $84.9M AUM 18.68% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EIP
Energy Income Partners Westport, Connecticut $6.22B AUM 18.97% 1-Year Est. Return

PharVision Advisers's KRP Position: Q3 2025 in Review

PharVision Advisers sold out of Kimbell Royalty Partners (KRP) in Q3 2025, closing a stake of 12,913 shares — an estimated $180K sold.

PharVision Advisers first reported a position in KRP in Q2 2025 and held it in 1 quarter. The position peaked at $180K in Q2 2025. 184 funds tracked by Wall St. Rank hold KRP as of Q3 2025.

  • PharVision Advisers reported no remaining Kimbell Royalty Partners position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 12,913 Kimbell Royalty Partners shares in Q3 2025, an estimated $180K.
  • PharVision Advisers first reported a position in Kimbell Royalty Partners in Q2 2025 and held it in 1 quarter.
  • PharVision Advisers's Kimbell Royalty Partners position peaked at $180K in Q2 2025.
  • 184 funds tracked by Wall St. Rank held Kimbell Royalty Partners as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.